ArticleJournal of cancer research and clinical oncology2020

Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.

Ji Hyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.